Clinical Trial Update: Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab with chemotherapy and filgrastim in Burkitt's lymphoma or Burkitt's leukemia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Leukemia
• Burkitt Lymphoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Filgrastim (filgrastim)
• Rituximab (rituximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-10-22